J.-Å. Nilsson
Lund University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J.-Å. Nilsson.
Journal of Internal Medicine | 2000
G. Berglund; Peter Nilsson; Karl-Fredrik Eriksson; J.-Å. Nilsson; Bo Hedblad; H. Kristenson; Folke Lindgärde
Abstract. Berglund G, Nilsson P, Eriksson K‐F, Nilsson J‐Å, Hedblad B, Kristenson H, Lindgärde F (University Hospital, Malmö, Sweden). Long‐term outcome of the Malmö Preventive Project: mortality and cardiovascular morbidity. J Intern Med 2000; 247: 19–29.
Journal of Internal Medicine | 2004
Anders Christensson; Anders Grubb; J.-Å. Nilsson; Kristina Norrgren; Gunnar Sterner; Göran Sundkvist
Objective. To determine whether serum cystatin C is more accurate than serum creatinine in the detection of diabetic nephropathy, also after adjustment for age.
Scandinavian Journal of Rheumatology | 2013
Ulf Bergström; L. Jacobsson; J.-Å. Nilsson; Elisabet Wirfält; Carl Turesson
Objective: Suggested predictors of rheumatoid arthritis (RA) include environmental exposure, such as smoking. Our purpose was to investigate potential predictors of RA in a nested case–control study based on a prospective cohort. Method: Between 1991 and 1996, 30 447 persons were included in the Malmö Diet and Cancer Study (MDCS). Individuals who developed RA after inclusion up to 31 December 2004 were identified by linking the database to different registers. Four controls were selected for every case. Data on lifestyle factors were collected in the MDCS. Results: We identified 172 incident cases of RA [36 men/136 women, mean age at diagnosis 63 years, 69% rheumatoid factor (RF) positive, median time from inclusion to diagnosis 5 (range 1–13) years]. In bivariate analyses, baseline smoking [odds ratio (OR) 2.02, 95% confidence interval (CI) 1.31–3.12] and a low level of formal education (i.e. ≤ 8 years; OR 2.42, 95% CI 1.18–4.93 vs. University degree) predicted subsequent development of RA. Infrequent baseline alcohol consumption was a predictor of RA (OR 3.47, 95% CI 1.91–6.30) compared to recent use (within the past month), and individuals with moderate baseline alcohol consumption (3.5–15.2 g/day vs. < 3.5 g/day) tended to have a reduced risk of RA (OR 0.48, 95% CI 0.22–1.05) in multivariate analyses, adjusted for smoking and level of education. Conclusions: Smoking and a low level of formal education were found to be independent predictors of RA. Moderate alcohol consumption may also be associated with a reduced risk.
Journal of Internal Medicine | 2008
Göran K. Hansson; J.-Å. Nilsson
For the third time, the Journal of Internal Medicine has organized a symposium to discuss the emerging concept of vascular inflammation as a pathogenetic mechanism underlying the pathogenesis of vascular diseases. At the first one, in 1988, the focus was on the vasculitides but new controversial ideas were presented regarding the role of inflammatory ⁄ immune mechanisms in atherosclerosis. They were largely based on analysis of human plaques and on cell culture studies.
Scandinavian Journal of Rheumatology | 2012
Britt-Marie Nyhäll-Wåhlin; Ingemar F. Petersson; Jacobsson C; Pierre Geborek; J.-Å. Nilsson; Nilsson K; L. Jacobsson; Carl Turesson
Objectives: To determine the incidence of severe extra-articular rheumatoid arthritis (ExRA) in a community-based cohort of RA patients, and to evaluate whether treatment with tumour necrosis factor (TNF) inhibitors has any effect on the risk of ExRA. Methods: In a review of clinical records from 1 July 1997 to 31 December 2004, severe ExRA manifestations were classified according to predefined criteria. Patients were censored at the development of ExRA, death, emigration, or 31 December 2004. Exposure to anti-TNF treatment has continuously and independently been recorded as part of a regional follow-up system. Results: During treatment with TNF inhibitors, there were two patients with new onset of ExRA in 408 person-years at risk (pyr) [0.49/100 pyr, 95% confidence interval (CI) 0.06–1.77]. Among those without anti-TNF treatment there were 63 patients with ExRA in 5425 pyr (1.16/100 pyr, 95% CI 0.89–1.49). The relative risk comparing those treated to those not treated with TNF inhibitors was 0.42 (95% CI 0.10–1.73). Conclusion: Our data show a lower incidence of ExRA in patients treated with TNF inhibitors but further studies with a larger sample size are needed for a more accurate estimate of the size of the effect.
Journal of Internal Medicine | 2017
Anton Gisterå; Ann Hermansson; Daniela Strodthoff; M. L. Klement; Ulf Hedin; Gunilla Nordin Fredrikson; J.-Å. Nilsson; Göran K. Hansson; Daniel F.J. Ketelhuth
The T‐cell response to low‐density lipoprotein (LDL) in the vessel wall plays a critical role in atherosclerotic plaque formation and stability. In this study, we used a new translational approach to investigate epitopes from human apolipoprotein B100 (ApoB100), the protein component of LDL, which triggers T‐cell activation. We also evaluated the potential of two selected native ApoB100 epitopes to modulate atherosclerosis in human ApoB100‐transgenic Ldlr−/− (HuBL) mice.
Scandinavian Journal of Rheumatology | 2013
Roger Hesselstrand; J.-Å. Nilsson; Gunnel Sandqvist
Objectives: To translate the visual analogue scales (VAS) in the Scleroderma Health Assessment Questionnaire (SSc HAQ) and the Cochin Hand Function Scale (CHFS) and to examine the reliability and validity of the Swedish versions of the instruments. Method: The reproducibility, internal consistency, acceptability, and validity of the instruments were evaluated. Eighty-three consecutive patients participated in the evaluation of the SSc HAQ and 56 in the CHFS. Sixty-six per cent fulfilled the criteria for limited systemic sclerosis (lcSSc) and 29% for diffuse systemic sclerosis (dcSSc). The patients were assessed regarding disease parameters, hand involvement, and quality of life, the latter using the 36-item short form health survey (SF-36). Results: The reproducibility in the HAQ Disability Index (HAQ-DI), the VAS of pulmonary, digital ulcer, and overall disease severity, and in the CHFS was good (intra-class correlation coefficients, ICCs ≥ 0.75). The internal consistency was high in the HAQ-DI and the CHFS but lower in the VAS. The HAQ-DI showed higher correlations coefficients with physical-related scores in the SF-36 (rs = –0.600) than with mental-related dimensions (rs = –0.235). All VAS showed significant correlation with the item for general health (p < 0.05). The CHFS showed high correlation to hand-related items in the HAQ (rs = 0.858) and moderate correlation to the physical summary score in SF-36 (rs = –0.521). The instruments could not discriminate between lcSSc and dcSSc, although significant correlations between the CHFS and hand involvement (p < 0.05) indicate the ability of the CHFS to discriminate between mild and severe hand involvement. Conclusions: The Swedish version of the SSc HAQ and the CHFS meet the requirements of reproducibility and concurrent validity. More studies are needed to examine the capacity of these instruments to discriminate between disease severities.
Lupus | 2015
P Malcus Johnsson; Gunnel Sandqvist; J.-Å. Nilsson; Anders Bengtsson; Gunnar Sturfelt; Ola Nived
This clinical study was performed to investigate hand problems in individuals with systemic lupus erythematosus (SLE) in comparison with healthy controls, and to explore problems in the performance of daily activities related to these hand problems, in order to objectify findings from a previous mail survey. We also investigated whether a simple hand test could detect hand problems in SLE. All individuals, 71 with SLE and 71 healthy controls, were examined for manifestations in body structures and body functions of the hands with a study-specific protocol. The simple hand test was performed by all the individuals and the arthritis impact measurement scale (AIMS 2) questionnaire was completed by the SLE individuals. In the SLE group, 58% had some kind of difficulty in the simple hand test, compared with 8% in the control group. Fifty percent of the SLE individuals experienced problems in performing daily activities due to hand deficits. Pain in the hands, reduced strength and dexterity, Raynaud’s phenomenon and trigger finger were the most prominent body functions affecting the performance of daily activities. Deficits in hand function are common in SLE and affect the performance of daily activities. The simple hand test may be a useful tool in detecting hand problems.
Journal of Internal Medicine | 2018
Jens O. Lagerstedt; Jonathan Dalla-Riva; Goran Marinkovic; R. Del Giudice; Daniel Engelbertsen; J. Burlin; Jitka Petrlova; Maria Lindahl; Katja Bernfur; Olle Melander; J.-Å. Nilsson; Alexandru Schiopu
IgG antibodies against apolipoprotein A‐I (ApoA‐I) have been found to be elevated in subjects from the general population with clinically manifest cardiovascular disease and in myocardial infarction patients with an adverse prognosis. Here, we investigated whether these antibodies are prospectively associated with carotid artery disease progression and with the risk for first‐time cardiovascular events in individuals with no previous history of cardiovascular disease.
Journal of Internal Medicine | 2018
S. Holm Nielsen; Christoffer Tengryd; Andreas Edsfeldt; Susanne Brix; Federica Genovese; Eva Bengtsson; Morten A. Karsdal; Diana Julie Leeming; J.-Å. Nilsson; Isabel Gonçalves
Atherosclerosis is characterized by accumulation of lipids, cells and extracellular matrix (ECM) proteins in the arterial wall. Collagen type I (COL1), a component of the arterial ECM, is cleaved by matrix metalloproteinases (MMPs) and known to be remodelled in atherosclerosis. We explored whether the MMP‐mediated COL1 biomarker, C1M, was associated with cardiovascular events, cardiovascular mortality and all‐cause mortality in a large prospective cohort of patients with known atherosclerosis.